Brochure | November 12, 2021

Developing Next Generation mAb Process Using 3M™ Zeta Plus™ Depth Filter, 3M™ Emphaze™ AEX Hybrid Purifier And 3M™ Polisher ST

Source: 3M Biopharmaceutical Purification
scientist research data iStock-1140779713

Biopharmaceutical companies are now riding the wave for extensive Single Use Technology (SUT) integration to design flexible facility layouts. With the implementation of these SUTs, the optimization of downstream processing workflows will continue to accelerate over the next 3 years.

While upstream processing has led to increasing yields, downstream processing has remained a costly bottleneck: advances in titers over the past two-decade shift the main manufacturing costs from USP towards DSP. There is a lot space for improvement in DSP by leveraging process intensification techniques that allow replacing multi-use steps with high regulatory burden by single use solutions.

3M has put together several platforms relating to each other in unique ways which stand to revolutionize bio-pharmaceutical manufacturing.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online

3M Biopharmaceutical Purification